Literature DB >> 22078164

Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature.

Michelle C Sabo1, Vincent C Luca, Stuart C Ray, Jens Bukh, Daved H Fremont, Michael S Diamond.   

Abstract

A recent study with flaviviruses suggested that structural dynamics of the virion impact antibody neutralization via exposure of ostensibly cryptic epitopes. To determine whether this holds true for the distantly related hepatitis C virus (HCV), whose neutralizing epitopes may be obscured by a glycan shield, apolipoprotein interactions, and the hypervariable region on the E2 envelope protein, we assessed how time and temperature of pre-incubation altered monoclonal antibody (MAb) neutralization of HCV. Notably, several MAbs showed increased inhibitory activity when pre-binding was performed at 37°C or after longer pre-incubation periods, and a corresponding loss-of-neutralization was observed when pre-binding was performed at 4°C. A similar profile of changes was observed with acute and chronic phase sera from HCV-infected patients. Our data suggest that time and temperature of incubation modulate epitope exposure on the conformational ensembles of HCV virions and thus, alter the potency of antibody neutralization.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22078164      PMCID: PMC3356770          DOI: 10.1016/j.virol.2011.10.023

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  65 in total

1.  Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding.

Authors:  Kathleen McCaffrey; Irene Boo; Pantelis Poumbourios; Heidi E Drummer
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

2.  Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry.

Authors:  Claire Bertaux; Tatjana Dragic
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.

Authors:  Theodore Oliphant; Grant E Nybakken; Michael Engle; Qing Xu; Christopher A Nelson; Soila Sukupolvi-Petty; Anantha Marri; Bat-El Lachmi; Udy Olshevsky; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

4.  High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.

Authors:  Marlène Dreux; Thomas Pietschmann; Christelle Granier; Cécile Voisset; Sylvie Ricard-Blum; Philippe-Emmanuel Mangeot; Zhenyong Keck; Steven Foung; Ngoc Vu-Dac; Jean Dubuisson; Ralf Bartenschlager; Dimitri Lavillette; Francois-Loïc Cosset
Journal:  J Biol Chem       Date:  2006-05-04       Impact factor: 5.157

5.  The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.

Authors:  Theodore C Pierson; Qing Xu; Steevenson Nelson; Theodore Oliphant; Grant E Nybakken; Daved H Fremont; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2007-04-19       Impact factor: 21.023

6.  Cryo-electron microscopy and three-dimensional reconstructions of hepatitis C virus particles.

Authors:  Xuekui Yu; Ming Qiao; Ivo Atanasov; Zongyi Hu; Takanobu Kato; T Jake Liang; Z Hong Zhou
Journal:  Virology       Date:  2007-07-05       Impact factor: 3.616

7.  Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.

Authors:  Thomas von Hahn; Joo Chun Yoon; Harvey Alter; Charles M Rice; Barbara Rehermann; Peter Balfe; Jane A McKeating
Journal:  Gastroenterology       Date:  2006-12-03       Impact factor: 22.682

8.  Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites.

Authors:  Karin Stiasny; Stefan Kiermayr; Heidemarie Holzmann; Franz X Heinz
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

9.  Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry.

Authors:  Donna M Tscherne; Christopher T Jones; Matthew J Evans; Brett D Lindenbach; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

10.  Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

Authors:  Alexander W Tarr; Ania M Owsianka; Judith M Timms; C Patrick McClure; Richard J P Brown; Timothy P Hickling; Thomas Pietschmann; Ralf Bartenschlager; Arvind H Patel; Jonathan K Ball
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

View more
  22 in total

Review 1.  Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.

Authors:  Laura A VanBlargan; Leslie Goo; Theodore C Pierson
Journal:  Microbiol Mol Biol Rev       Date:  2016-10-26       Impact factor: 11.056

2.  Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition.

Authors:  Kimberly A Dowd; Swati Mukherjee; Richard J Kuhn; Theodore C Pierson
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

3.  Antigenic cooperation among intrahost HCV variants organized into a complex network of cross-immunoreactivity.

Authors:  Pavel Skums; Leonid Bunimovich; Yury Khudyakov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

4.  Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.

Authors:  Jannick Prentoe; Rodrigo Velázquez-Moctezuma; Elias H Augestad; Andrea Galli; Richard Wang; Mansun Law; Harvey Alter; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-30       Impact factor: 11.205

Review 5.  Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host.

Authors:  Richard J Kuhn; Kimberly A Dowd; Carol Beth Post; Theodore C Pierson
Journal:  Virology       Date:  2015-03-30       Impact factor: 3.616

6.  Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.

Authors:  Erick Giang; Marcus Dorner; Jannick C Prentoe; Marlène Dreux; Matthew J Evans; Jens Bukh; Charles M Rice; Alexander Ploss; Dennis R Burton; Mansun Law
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-04       Impact factor: 11.205

7.  Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.

Authors:  Rodrigo Velázquez-Moctezuma; Andrea Galli; Mansun Law; Jens Bukh; Jannick Prentoe
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

8.  Antibody Response to Hypervariable Region 1 Interferes with Broadly Neutralizing Antibodies to Hepatitis C Virus.

Authors:  Zhen-yong Keck; Christine Girard-Blanc; Wenyan Wang; Patrick Lau; Adam Zuiani; Felix A Rey; Thomas Krey; Michael S Diamond; Steven K H Foung
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

Review 9.  Flaviviruses: braking the entering.

Authors:  Theodore C Pierson; Margaret Kielian
Journal:  Curr Opin Virol       Date:  2013-01-24       Impact factor: 7.090

10.  Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.

Authors:  Soila Sukupolvi-Petty; James D Brien; S Kyle Austin; Bimmi Shrestha; Sherri Swayne; Kristen Kahle; Benjamin J Doranz; Syd Johnson; Theodore C Pierson; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.